A survey of 166 HIV organizations found 1,700 clinics closed after US funding cuts
Seventy-seven thousand fewer children got PEPFAR-supported HIV treatment in 2025 than the year before. UNAIDS warns permanent cuts could mean millions of additional infections and deaths by 2029.
A survey of 166 organizations across 46 countries that rely on PEPFAR, the US President's Emergency Plan for AIDS Relief, found more than 1,700 clinics closed and over 16,000 workers lost their jobs after this year's funding disruptions, according to results the HIV charity amfAR released 21 July [s1].
What the survey measured
amfAR's survey asked PEPFAR-funded organizations directly about the operational fallout from delayed or cancelled US funding awards during 2025 and into 2026 [s1]. Beyond the clinic-closure and job-loss figures, the survey found that roughly three-quarters of responding organizations had stopped serving high-risk populations — the groups PEPFAR programs have historically prioritized because they carry a disproportionate share of new HIV transmission [s1]. amfAR's Elise Lankiewicz summarized the pattern bluntly: "Disruption was incredibly widespread" [s1].
The treatment numbers behind the disruption
Globally, about 77,000 fewer children received PEPFAR-supported HIV treatment in 2025 than in 2024 — a 14% decline [s1]. PEPFAR, launched in 2003, is credited with having saved an estimated 26 million lives over its history [s1], which is the scale against which this year's disruption is being measured. The survey doesn't establish that every one of those 77,000 children lost treatment entirely — some may have found care through other channels — but a decline of that size in a single program category is a meaningful signal of strain on the broader system.
Why this isn't just a US story
UNAIDS separately lost a quarter of its own funding over the past year, and the article notes that France, Germany, and the UK have also reduced foreign assistance budgets over the same period [s1] — meaning PEPFAR's cuts are compounding, not offsetting, a broader pullback in international HIV funding from multiple donor governments simultaneously. UNAIDS executive director Winnie Byanyima framed the moment as forcing structural change rather than just belt-tightening: "There is a need for Africa to quickly adapt its systems... this is a moment of radical change" [s1].
The stakes if the funding gap persists
UNAIDS has projected that if the funding cuts become permanent rather than temporary, the world could see 6.6 million additional HIV infections and 4.2 million additional AIDS deaths by 2029 [s1]. That is a modeled projection, not a certainty — it depends on assumptions about how much of the lost capacity gets replaced by other funders or domestic health systems, which is precisely the "adaptation" Byanyima is calling for. The gap between what's already been measured (clinic closures, treatment declines in 2025) and what's projected (millions of infections and deaths by 2029) is the difference between documented harm and a forecast that assumes no further intervention.
What to watch next
Whether the disrupted PEPFAR funding gets restored, replaced by other donors, or absorbed into domestic health budgets in the affected countries — and whether the 2026 treatment numbers, once tallied, show the 2025 decline stabilizing, deepening, or reversing. The amfAR survey covers only the organizations that responded, so it likely understates rather than overstates the full scope of disruption across all PEPFAR-funded programs globally.
Sources
- US funding cuts deal blow to global HIV treatment: Report — Al Jazeera , July 21, 2026
More on
A $936 million health agreement with Malawi shows what replaced U.S. foreign aid
Washington intends to provide up to $792 million over five years. Malawi commits the rest — and the money is meant to flow through the government rather than NGOs.
The first hard numbers on what the PEPFAR stop-work orders did to HIV services
Across 165 clinics in four African countries, HIV testing fell by up to 35% and treatment starts by up to 32%. Most services had not returned to baseline two months after the orders were lifted.
A one-year PEPFAR PrEP pause models out to 6,671 extra HIV infections
The modelling study puts 719,384 people on PEPFAR-funded oral PrEP in 28 African countries at the end of 2024. Most projected infections fall on key populations whose coverage was already under 6%.
CDC strongly recommends twice-yearly lenacapavir as an HIV prevention option
The recommendation covers people weighing at least 35 kg and rests on two trials in which lenacapavir cut HIV infections by 100% and 96% against background incidence.